Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Laryngol Otol ; 134(12): 1103-1107, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33431081

RESUMO

OBJECTIVE: Wide-ranging outcomes have been reported for surgical and non-surgical management of T3 laryngeal carcinomas. This study compared the outcomes of T3 tumours treated with laryngectomy or (chemo)radiotherapy in the northeast of England. METHODS: The outcomes of T3 laryngeal carcinoma treatment at three centres (2007-2016) were retrospectively analysed using descriptive statistics and survival curves. RESULTS: Of 179 T3 laryngeal carcinomas, 68 were treated with laryngectomies, 57 with chemoradiotherapy and 32 with radiotherapy. There was no significant five-year survival difference between treatment with laryngectomy (34.1 per cent) and chemoradiotherapy (48.6 per cent) (p = 0.184). The five-year overall survival rate for radiotherapy (12.5 per cent) was significantly inferior compared to laryngectomy and chemoradiotherapy (p = 0.003 and p < 0.001, respectively). The recurrence rates were 22.1 per cent for laryngectomy, 17.5 per cent for chemoradiotherapy and 50 per cent for radiotherapy. There were significant differences in recurrence rates when laryngectomy (p = 0.005) and chemoradiotherapy (p = 0.001) were compared to radiotherapy. CONCLUSION: Laryngectomy and chemoradiotherapy had significantly higher five-year overall survival and lower recurrence rates compared with radiotherapy alone. Laryngectomy should be considered in patients unsuitable for chemotherapy, as it may convey a significant survival advantage over radiotherapy alone.


Assuntos
Carcinoma/terapia , Quimiorradioterapia/métodos , Neoplasias Laríngeas/patologia , Laringectomia/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Quimiorradioterapia/estatística & dados numéricos , Inglaterra/epidemiologia , Feminino , Humanos , Neoplasias Laríngeas/mortalidade , Laringectomia/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica/patologia , Recidiva Local de Neoplasia/epidemiologia , Radioterapia/métodos , Radioterapia/estatística & dados numéricos , Análise de Sobrevida , Taxa de Sobrevida , Resultado do Tratamento , Adulto Jovem
2.
Cell Mol Life Sci ; 61(19-20): 2597-613, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15526165

RESUMO

Early studies of the inhibitor of growth 1 ( ING1) gene, the founding member of the ING tumor suppressor family, demonstrated that this gene plays an important role in apoptosis and cellular senescence. Four other related genes have since been identified and found to be involved in various biological activities, including cell cycle arrest, regulation of gene transcription, DNA repair and apoptosis. The biochemical functions of ING proteins as histone acetyltransferases and histone deacetylase co-factors ties this new tumor suppressor family to the regulation of transcription, cell cycle check-points, DNA repair and apoptosis. This review is aimed at summarizing the known biological functions of the ING tumor suppressors and the signalling pathways that they involve.


Assuntos
Apoptose , Proteínas/fisiologia , Acetilação , Animais , Ciclo Celular , Proteínas de Ciclo Celular , Linhagem Celular Tumoral , Senescência Celular , Reparo do DNA , Proteínas de Ligação a DNA , Genes Supressores de Tumor , Histonas/metabolismo , Humanos , Proteína 1 Inibidora do Crescimento , Peptídeos e Proteínas de Sinalização Intracelular , Modelos Biológicos , Modelos Genéticos , Mutação , Proteínas Nucleares , Fosfatidilinositóis/química , Estrutura Terciária de Proteína , Transcrição Gênica , Proteína Supressora de Tumor p53/metabolismo , Proteínas Supressoras de Tumor
3.
West J Med ; 156(4): 380-4, 1992 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1574880

RESUMO

We report a series of 5 representative patients in California who experienced adverse reactions from the illicitly marketed substance gamma-hydroxybutyrate (GHB). The drug is a putative neurotransmitter marketed as a growth hormone releaser for bodybuilders. The most commonly reported symptoms included abrupt drowsiness, dizziness, and a "high". Other effects were headache, nausea, vomiting, myoclonic jerking, and short-term coma. There have been no reported deaths. If product use is discontinued, full recovery with no long-term side effects is universal. No clear dose-response effect was observed; this may be attributable to differences in susceptibility, wide variations in doses taken by the same person, or the coingestion of other substances. Case interviews confirm that, despite being banned by the US Food and Drug Administration, GHB is still widely available in the underground drug market. Athletes and bodybuilders may take drugs for which there are claims of improved performance or body image. Physicians should be alert for signs of GHB poisoning in emergency department and clinic patients.


Assuntos
Oxibato de Sódio/intoxicação , Adulto , Idoso , California , Interações Medicamentosas , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Convulsões/induzido quimicamente , Sensação/efeitos dos fármacos , Fases do Sono , Oxibato de Sódio/química , Oxibato de Sódio/metabolismo
4.
Ann Intern Med ; 112(7): 539-43, 1990 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-2316942

RESUMO

STUDY OBJECTIVE: During 1987, the rate of syphilis among heterosexual adults in Oregon increased 159%, yet the number of cases of gonorrhea remained stable. Our study was done to evaluate why the same control measures contained gonorrhea but not syphilis in this population. DESIGN: Exploratory case-control study. SETTING: Public health clinics in Portland, and Salem, Oregon. PATIENTS: All 146 heterosexual adults with early syphilis and all 164 heterosexual adults with acute gonorrhea reported to the public health clinics during April to July 1988. INTERVENTION: A questionnaire was administered to all syphilis case-patients and control patients (those with gonorrhea) at the beginning of the routine, sexually transmitted disease (STD), investigative interview. MEASUREMENTS AND MAIN RESULTS: Syphilis case-patients had contact with an average of 5.0 sex partners for whom they could not supply locating information sufficient to initiate partner notification. In contrast, patients with gonorrhea had contact with an average of 0.4 sex partners for whom they could not supply locating information (P less than 0.005). The 28% (41 of 146) of syphilis case-patients who reported having exchanged sex for drugs or money accounted for 72% (527 of 729) of the unlocatable partners exposed to syphilis. In contrast, the 17% (28 of 164) of patients with gonorrhea who reported having exchanged sex for drugs or money accounted for 36% (25 of 69) of the unlocatable partners exposed to gonorrhea. CONCLUSIONS: Because patients infected with syphilis have relatively large numbers of anonymous sexual encounters, prevention strategies that supplement partner notification are urgently needed to control the syphilis epidemic among adults.


Assuntos
Surtos de Doenças/prevenção & controle , Parceiros Sexuais , Sífilis/prevenção & controle , Adolescente , Adulto , Negro ou Afro-Americano , Estudos de Casos e Controles , Distribuição de Qui-Quadrado , Feminino , Gonorreia/epidemiologia , Política de Saúde , Humanos , Recém-Nascido , Masculino , Razão de Chances , Oregon/epidemiologia , Fatores de Risco , Trabalho Sexual , Comportamento Sexual , Transtornos Relacionados ao Uso de Substâncias/complicações , Sífilis/epidemiologia , Sífilis/etnologia , Sífilis/transmissão , Sífilis Congênita/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA